Biologic agents in rheumatology: safety considerations.
Lee
Susan J
SJ
Division of Rheumatology, Allergy, and Immunology, The University of California, San Diego, USA. s2lee@ucsd.edu
Kavanaugh
Arthur
A
D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000493:pharmacokinetics; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D006801:Humans; D007155:Immunologic Factors / Q000009:adverse effects* / Q000493:pharmacokinetics; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000493:pharmacokinetics; D012219:Rheumatology / Q000379:methods
D018501:Antirheumatic Agents; D007155:Immunologic Factors; D007166:Immunosuppressive Agents